Keywords: UCB, Majority stake, M&A, Meizler Biophama, Brazil

UCB buys majority stake in local drugmaker to expand in Brazil

Article | 31 May 2012

Print This

Belgium’s leading pharma company UCB (Euronext Brussels: UCB) says it has signed an agreement to acquire a 51% stake ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in